ScienceDex / Researcher record
Daniela Salvemini
- Saint Louis University · Pharmacology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #2,314
- R01 Holder
- Translational
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $3,217,944 | 5 | #2,314 |
| 2025 | $2,090,664 | 4 | #6,225 |
| 2026 | $2,598,824 | 5 | #7,446 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected5 records
- FY20254 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8526936Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pharmacology
- OTHER BASIC SCIENCES
FY2024 award records by amount
NIH award records listing Daniela Salvemini as a PI. Multi-PI records show the full award amount for context.
- 1R61NS138976-01R61Contact PIDevelopment of selective GPR34 antagonists for the treatment of neuropathic painSaint Louis University · Pharmacology (NIH department code)$1.5Maward amount
- 1R01NS138127-01R01Co-investigatorMolecular basis for functional S1PR1 antagonists in the treatment of comorbid migraine and temporomandibular disordersUniversity of Maryland Baltimore · Other Basic Sciences (NIH department code)$620.3Kaward amount
- 5R01CA261979-03R01Contact PIFingolimod and Ozanimod for the treatment and prevention of chemobrainSaint Louis University · Pharmacology (NIH department code)$458.8Kaward amount
- 5R01NS120930-03R01Co-investigatorMolecular basis for adenosine A3 receptor agonists in the treatment of migraineUniversity of Maryland Baltimore · Other Basic Sciences (NIH department code)$458.7Kaward amount
- 5R21CA277436-02R21Contact PIGPR160 antibody development for cancer treatmentSaint Louis University · Pharmacology (NIH department code)$168.2Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Daniela Salvemini as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSaint Louis University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2314
- 2024Entered Top 25% NationallyRanked #2314
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Daniela Salvemini.